A Case For Transparency: J&J Suit Targets Opaque PBM Affiliate’s Efforts To Exploit Copay Programs

Lawsuit highlights the lack of transparency into pharmacy benefit manager activities and how their programs can influence drug pricing. A Senate hearing on PBMs held shows increasing momentum behind a Federal Trade Commission study on potential anti-competitive activity in the market sector.

It's Tough To Reform What You Can't See • Source: Alamy

Johnson & Johnson is seeking an injunction barring an under-the-radar drug copay program administered by SaveOnSP LLC from continuing to “pilfer tens of millions of dollars” from J&J’s patient assistance program for its own financial benefit and those of its payer clients, according to a complaint filed in US federal court for the District of New Jersey 4 May.

SaveOnSP operates the program in partnership with pharmacy benefit manager Express Scripts Holding Company and its Accredo specialty pharmacy,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet